Hematopoietic and Lymphatic System Neoplasm

Hematopoietic and Lymphatic System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

18,832 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 851–900 of 3,485 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00217425	Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms	completed	Phase 2	46	Eastern Cooperative Oncology GroupNETWORK	1	Jun 18, 2023	clinicaltrials
NCT01618136	An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors	completed	Phase 1 / Phase 2	41	Eisai Limited